Estamos no ar no !
Saiba mais
CDAK
Codiak BioSciences
Deslistada
CDAK foi retirado da bolsa em 4 de abril de 2023.
Sobre: Codiak BioSciences Inc is a development-stage biopharmaceutical company focused on the development of exosome-based therapeutics for the treatment of a wide spectrum of diseases with high unmet medical need. The company have utilized engEx Platform to generate a pipeline of engineered exosomes, aimed at treating a broad range of diseases, including oncology, neuro-oncology, neurology, neuromuscular disease, infectious disease and rare disease.
Funcionários: 53
Notícias
Positiva
Neutra
Negativa
Sentimento
3 meses
Positiva
0%
Neutra
0%
Negativa
0%
Não recebemos notícias recentes sobre CDAK
Gráficos de preços implementados com Lightweight Charts™